Pre-order Enquiry
Request Free Sample
Global Anti-CD20 Monoclonal Antibodies Market Research Report 2022
SKU ID : QYR-21415788 | Publishing Date : 03-Aug-2022 | No. of pages : 91
Detailed TOC of Global Anti-CD20 Monoclonal Antibodies Market Research Report 2022
1 Anti-CD20 Monoclonal Antibodies Market Overview1.1 Product Overview and Scope of Anti-CD20 Monoclonal Antibodies
1.2 Anti-CD20 Monoclonal Antibodies Segment by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Anti-CD20 Monoclonal Antibodies Segment by Application
1.3.1 Global Anti-CD20 Monoclonal Antibodies Sales Comparison by Application: (2022-2028)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Global Anti-CD20 Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Anti-CD20 Monoclonal Antibodies Revenue 2017-2028
1.4.2 Global Anti-CD20 Monoclonal Antibodies Sales 2017-2028
1.4.3 Anti-CD20 Monoclonal Antibodies Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-CD20 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-CD20 Monoclonal Antibodies Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-CD20 Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
2.5 Anti-CD20 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Anti-CD20 Monoclonal Antibodies Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-CD20 Monoclonal Antibodies Players Market Share by Revenue
2.5.3 Global Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.3.1 North America Anti-CD20 Monoclonal Antibodies Sales by Country
3.3.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Country
3.4.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region
3.5.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country
3.6.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country
3.7.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-CD20 Monoclonal Antibodies Historic Market Analysis by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2017-2022)
4.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
4.3 Global Anti-CD20 Monoclonal Antibodies Price by Type (2017-2022)
5 Global Anti-CD20 Monoclonal Antibodies Historic Market Analysis by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2017-2022)
5.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2017-2022)
5.3 Global Anti-CD20 Monoclonal Antibodies Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Genmab
6.1.1 Genmab Corporation Information
6.1.2 Genmab Description and Business Overview
6.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Genmab Anti-CD20 Monoclonal Antibodies Product Portfolio
6.1.5 Genmab Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Amgen Anti-CD20 Monoclonal Antibodies Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Celltrion
6.3.1 Celltrion Corporation Information
6.3.2 Celltrion Description and Business Overview
6.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Product Portfolio
6.3.5 Celltrion Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Roche Anti-CD20 Monoclonal Antibodies Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biogen Anti-CD20 Monoclonal Antibodies Product Portfolio
6.7.5 Biogen Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Corporation Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Genentech Anti-CD20 Monoclonal Antibodies Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 Immunomedics
6.9.1 Immunomedics Corporation Information
6.9.2 Immunomedics Description and Business Overview
6.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Product Portfolio
6.9.5 Immunomedics Recent Developments/Updates
6.10 Spectrum Pharmaceuticals
6.10.1 Spectrum Pharmaceuticals Corporation Information
6.10.2 Spectrum Pharmaceuticals Description and Business Overview
6.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product Portfolio
6.10.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.11 Bio-Rad Laboratories
6.11.1 Bio-Rad Laboratories Corporation Information
6.11.2 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Description and Business Overview
6.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product Portfolio
6.11.5 Bio-Rad Laboratories Recent Developments/Updates
6.12 LFB Biotechnologie
6.12.1 LFB Biotechnologie Corporation Information
6.12.2 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Description and Business Overview
6.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2017-2022)
6.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product Portfolio
6.12.5 LFB Biotechnologie Recent Developments/Updates
7 Anti-CD20 Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Anti-CD20 Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
7.4 Anti-CD20 Monoclonal Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-CD20 Monoclonal Antibodies Distributors List
8.3 Anti-CD20 Monoclonal Antibodies Customers
9 Anti-CD20 Monoclonal Antibodies Market Dynamics
9.1 Anti-CD20 Monoclonal Antibodies Industry Trends
9.2 Anti-CD20 Monoclonal Antibodies Market Drivers
9.3 Anti-CD20 Monoclonal Antibodies Market Challenges
9.4 Anti-CD20 Monoclonal Antibodies Market Restraints
10 Global Market Forecast
10.1 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Type (2023-2028)
10.2 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Application (2023-2028)
10.3 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-CD20 Monoclonal Antibodies by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-CD20 Monoclonal Antibodies by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Anti-CD20 Monoclonal Antibodies Market Research Report 2022
List of TablesTable 1. Global Anti-CD20 Monoclonal Antibodies Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Anti-CD20 Monoclonal Antibodies Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Anti-CD20 Monoclonal Antibodies Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Anti-CD20 Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2021
Table 5. Global Anti-CD20 Monoclonal Antibodies Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Anti-CD20 Monoclonal Antibodies Average Price (USD/KG) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Anti-CD20 Monoclonal Antibodies Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-CD20 Monoclonal Antibodies Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-CD20 Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 16. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 17. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 19. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 20. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2017-2022)
Table 21. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
Table 23. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 24. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2017-2022)
Table 25. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 31. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 32. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2017-2022)
Table 33. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
Table 39. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 40. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2017-2022)
Table 41. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2017-2022)
Table 43. Global Anti-CD20 Monoclonal Antibodies Price by Type (2017-2022) & (USD/KG)
Table 44. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2017-2022)
Table 45. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2017-2022)
Table 46. Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2017-2022)
Table 48. Global Anti-CD20 Monoclonal Antibodies Price by Application (2017-2022) & (USD/KG)
Table 49. Genmab Corporation Information
Table 50. Genmab Description and Business Overview
Table 51. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 52. Genmab Anti-CD20 Monoclonal Antibodies Product
Table 53. Genmab Recent Developments/Updates
Table 54. Amgen Corporation Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 57. Amgen Anti-CD20 Monoclonal Antibodies Product
Table 58. Amgen Recent Developments/Updates
Table 59. Celltrion Corporation Information
Table 60. Celltrion Description and Business Overview
Table 61. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 62. Celltrion Anti-CD20 Monoclonal Antibodies Product
Table 63. Celltrion Recent Developments/Updates
Table 64. Roche Corporation Information
Table 65. Roche Description and Business Overview
Table 66. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 67. Roche Anti-CD20 Monoclonal Antibodies Product
Table 68. Roche Recent Developments/Updates
Table 69. Novartis AG Corporation Information
Table 70. Novartis AG Description and Business Overview
Table 71. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 72. Novartis AG Anti-CD20 Monoclonal Antibodies Product
Table 73. Novartis AG Recent Developments/Updates
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 77. Pfizer Anti-CD20 Monoclonal Antibodies Product
Table 78. Pfizer Recent Developments/Updates
Table 79. Biogen Corporation Information
Table 80. Biogen Description and Business Overview
Table 81. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 82. Biogen Anti-CD20 Monoclonal Antibodies Product
Table 83. Biogen Recent Developments/Updates
Table 84. Genentech Corporation Information
Table 85. Genentech Description and Business Overview
Table 86. Genentech Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 87. Genentech Anti-CD20 Monoclonal Antibodies Product
Table 88. Genentech Recent Developments/Updates
Table 89. Immunomedics Corporation Information
Table 90. Immunomedics Description and Business Overview
Table 91. Immunomedics Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 92. Immunomedics Anti-CD20 Monoclonal Antibodies Product
Table 93. Immunomedics Recent Developments/Updates
Table 94. Spectrum Pharmaceuticals Corporation Information
Table 95. Spectrum Pharmaceuticals Description and Business Overview
Table 96. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 97. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product
Table 98. Spectrum Pharmaceuticals Recent Developments/Updates
Table 99. Bio-Rad Laboratories Corporation Information
Table 100. Bio-Rad Laboratories Description and Business Overview
Table 101. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 102. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product
Table 103. Bio-Rad Laboratories Recent Developments/Updates
Table 104. LFB Biotechnologie Corporation Information
Table 105. LFB Biotechnologie Description and Business Overview
Table 106. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 107. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product
Table 108. LFB Biotechnologie Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Anti-CD20 Monoclonal Antibodies Distributors List
Table 112. Anti-CD20 Monoclonal Antibodies Customers List
Table 113. Anti-CD20 Monoclonal Antibodies Market Trends
Table 114. Anti-CD20 Monoclonal Antibodies Market Drivers
Table 115. Anti-CD20 Monoclonal Antibodies Market Challenges
Table 116. Anti-CD20 Monoclonal Antibodies Market Restraints
Table 117. Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Type (2023-2028) & (KG)
Table 118. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Application (2023-2028) & (KG)
Table 122. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (KG)
Table 126. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-CD20 Monoclonal Antibodies
Figure 2. Global Anti-CD20 Monoclonal Antibodies Market Share by Type in 2021 & 2028
Figure 3. First Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 4. Second Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 5. Third Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 6. Global Anti-CD20 Monoclonal Antibodies Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Neurology
Figure 9. Immunology
Figure 10. Global Anti-CD20 Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Anti-CD20 Monoclonal Antibodies Market Size (2017-2028) & (US$ Million)
Figure 12. Global Anti-CD20 Monoclonal Antibodies Sales (2017-2028) & (KG)
Figure 13. Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturers in 2021
Figure 14. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Anti-CD20 Monoclonal Antibodies Players: Market Share by Revenue in 2021
Figure 16. Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Figure 18. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region in 2021
Figure 19. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Figure 20. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region in 2021
Figure 21. U.S. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Anti-CD20 Monoclonal Antibodies by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Anti-CD20 Monoclonal Antibodies
Figure 47. Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
Figure 48. Anti-CD20 Monoclonal Antibodies Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Keyplayers in Global Anti-CD20 Monoclonal Antibodies Market Research Report 2022
GenmabAmgen
Celltrion
Roche
Novartis AG
Pfizer
Biogen
Genentech
Immunomedics
Spectrum Pharmaceuticals
Bio-Rad Laboratories
LFB Biotechnologie
Request Sample
Request Discount
